More than 40% of journal papers about cancer trials are now being written by commercial medical writers rather than researchers, according to a new study that raises concerns the practice could result in conflicts of interest. The study found the use of professional medical writers (PMWs) – also known as ‘ghostwriters’ – was especially common ...
Ghostwriters used for almost half of oncology trials
By Megan Howe
28 Sep 2020